This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (422) Complementary and Alternative Medicine (109) Pharmacology and Pharmaceutics (120) Methods and Feasibility Studies (481)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/79579, first published .
Jiedu Xiaozhen Granules for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor–Mediated Skin Toxicity: Protocol for a Randomized Controlled Trial

Jiedu Xiaozhen Granules for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor–Mediated Skin Toxicity: Protocol for a Randomized Controlled Trial

Jiedu Xiaozhen Granules for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor–Mediated Skin Toxicity: Protocol for a Randomized Controlled Trial

Authors of this article:

Shoujiang Hao1 Author Orcid Image ;   Xiaoli Li2 Author Orcid Image ;   Shulan Hao2 ;   Xiaoying Zhang2 ;   Xiaojun Qi1 ;   Gang Jin3 ;   Fangfang Shen4 ;   Likun Liu2 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Shoujiang Hao   1 * , BMed ;   Xiaoli Li   2 * , MMed ;   Shulan Hao   2 , MMed ;   Xiaoying Zhang   2 , MMed ;   Xiaojun Qi   1 , MMed ;   Gang Jin   3 , MMed ;   Fangfang Shen   4 * , MMed ;   Likun Liu   2 * , MMed

1 Shanxi University of Traditional Chinese Medicine, Taiyuan, China

2 Shanxi Province Hospital of Traditional Chinese Medicine, Taiyuan, Shanxi, China

3 The Second Affiliated Hospital of Shanxi Medical University, Taiyuan, China

4 Shanxi Provincial Cancer Hospital, Taiyuan, China

*these authors contributed equally

Corresponding Author:

  • Likun Liu, MMed
  • Shanxi Province Hospital of Traditional Chinese Medicine
  • 46 Bingzhou West Street, Yingze District
  • Taiyuan, Shanxi 030012
  • China
  • Phone: 86 17631765869
  • Email: llkun133@126.com